Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 10981906
APP PUB NO 20190135808A1
SERIAL NO

16179695

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to new pyrrolopyridine compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibition of JAK1 and JAK3 kinase activity in a human or animal subject are also provided for the treatment diseases such as pruritus, alopecia, androgenetic alopecia, alopecia areata, vitiligo and psoriasis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ACLARIS THERAPEUTICS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Anderson, David Randolph Salem, US 20 61
Blinn, James Robert O'Fallon, US 26 60
Hockerman, Susan Landis Kirkwood, US 19 33
Jacobsen, Eric Jon Chesterfield, US 65 636

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Oct 20, 2024
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 20, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 20, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00